Bispecific digoxigenin-binding antibodies for targeted payload delivery-Reference-Cited by-同舟云学术

Bispecific digoxigenin-binding antibodies for targeted payload delivery

Published:2011-05-02 Issue:20 Volume:108 Page:8194-8199
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Metz S.,Haas A. K.,Daub K.,Croasdale R.,Stracke J.,Lau W.,Georges G.,Josel H.-P.,Dziadek S.,Hopfner K.-P.,Lammens A.,Scheuer W.,Hoffmann E.,Mundigl O.,Brinkmann U.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference34 articles.

1. Strategies and challenges for the next generation of therapeutic antibodies

2. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFα, anti-IL-1α/β and IL-1Ra

3. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment

4. Simultaneous Blockade of Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor Signaling Pathways in Cancer Cells with a Fully Human Recombinant Bispecific Antibody

5. A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor Activity

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Welding PROxAb Shuttles: A Modular Approach for Generating Bispecific Antibodies via Site-Specific Protein–Protein Conjugation;Bioconjugate Chemistry;2024-05-29

2. Welding PROxAb Shuttles: A modular approach for generating bispecific antibodies via site-specific protein-protein conjugation;2024-03-15

3. GB12-09, a bispecific antibody targeting IL4Rα and IL31Rα for atopic dermatitis therapy;Antibody Therapeutics;2024-01

4. Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment;Frontiers in Immunology;2023-12-01

5. PROxAb Shuttle: A non-covalent plug-and-play platform for the rapid generation of tumor-targeting antibody-PROTAC conjugates;2023-09-29